StockData
IGC Pharma, Inc. logo

IGC Pharma, Inc. (IGC) stock

IGCNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 2/3019% above fair value
$0.19+0.01 (+7.37%)

Close on Nov 17, 2026Market cap $19.43MP/E –Yield –

IGC Pharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

IGC Pharma's price to sales ratio was 18.1× on Nov 11, 2026, against 26.5× a year earlier. Over the last 5 years it ranged from 12.7× to 154.8×, with a median of 23.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202618.1×−5.3
2025Dec 31, 202523.4×+1.6
2024Dec 31, 202421.8×+8.5
2023Dec 29, 202313.3×−11.6
2022Dec 30, 202224.9×−129.9
2021Dec 31, 2021154.8×+105.6
2020Dec 31, 202049.1×+45.2
2019Dec 31, 20194.0×+1.7
2018Dec 31, 20182.3×+2.2
2017Dec 29, 20170.0×+0.0
2016Dec 30, 20160.0×+0.0
2015Dec 31, 20150.0×−0.0
2014Apr 30, 20140.0×+0.0
2013Dec 31, 20130.0×−0.0
2012Dec 31, 20120.0×–

More IGC Pharma figures

See a number that looks wrong?